Skip to Content

Safeguard Your Intellectual Property ®

SSJR Wins Patent Infringement Trial for Apotex Regarding Budesonide (Pulmicort Respules®)

On February 13, 2015, SSJR, for its client Apotex, won a patent trial against AstraZeneca, lifting an injunction and clearing the path for Apotex to enter the $1.1 billion annual Pulmicort Respules® market with a generic version of the popular asthma drug. SSJR will now be seeking damages as compensation […]

Read More

February 23, 2015 by in General